Elevated endocannabinoid plasma levels are associated with coronary circulatory dysfunction in obesity.

A, Quercioli; Z, Pataky; G, Vincenti; V, Makoundou; Marzo V, Di; F, Montecucco; S, Carballo; A, Thomas; C, Staub; S, Steffens; Y, Seimbille; A, Golay; O, Ratib; E, Harsch; F, Mach; TH, Schindler

doi:10.1093/eurheartj/ehr029

Public

Elevated endocannabinoid plasma levels are associated with coronary circulatory dysfunction in obesity.

Shared by NobleBlocks on Feb 8, 2011 • 12:00 AM UTC

Authors:

Quercioli A

Pataky Z

Vincenti G

Abstract

Aims Aim of this study was to evaluate a possible association between endocannabinoid (EC) plasma levels, such as anandamide (AEA) and 2-arachidonoylglycerol (2-AG), and coronary circulatory function in obesity.Methods and results Myocardial blood flow (MBF) responses to cold pressor test (CPT) and ...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!